ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Margaret K. Callahan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9087-0012; OpenAlex author ID A5011114578. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032). Co-author DOI 10.1136/jitc-2023-007883 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dung Thi Le · 1 shared paper, 2024 · strength 0.20
- Paper Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa… DOI 10.1136/jitc-2023-007883 ↗
Eileen Mary O'Reilly · 1 shared paper, 2024 · strength 0.20
- Paper Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa… DOI 10.1136/jitc-2023-007883 ↗
Padmanee Sharma · 1 shared paper, 2024 · strength 0.20
- Paper Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa… DOI 10.1136/jitc-2023-007883 ↗
Michael Andrew Morse · 1 shared paper, 2024 · strength 0.20
- Paper Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pa… DOI 10.1136/jitc-2023-007883 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.